All In Biotech

Drug Trial Radar · NCT06721988

Effect of Preventive Analgesia with Oxycodone and Parecoxib Sodium on the Chronification of Acute Post-operative Pain

Exploring the Effect of Preventive Analgesia with Oxycodone and Parecoxib Sodium on the Chronification of Acute Pain in Adult Patients Underwent Laparoscopic-assisted Abdominal Major Surgery

Last checked: Nov 19, 2026Latest source record: Dec 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 1,316 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

1,316

Planned (sponsor's estimate)

Start

Jan 1, 2025

Primary completion

Dec 31, 2026

Study completion Apr 30, 2027

Sponsor

Lead sponsor
Ailin LuoAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Jinhua Central Hospital; Minda Hospital of Hubei Minzu University; Taihe Hospital of Traditional Chinese Medicine; Qujing first people's Hospital
First posted
Dec 9, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if the administration of oxycodone for preventive analgesia works to reduce the chronification of acute postoperative pain in adult participants undergoing major abdominal surgery. The main question it aims to answer is: • Does administration of oxycodone before surgical incision reduce the occurrence of chronic pain or relieve the chronic pain symptoms 3 months after the operation? Researchers will compare oxycodone + parecoxib sodium to placebo + parecoxib sodium combinations to see if oxycodone works to reduce the chronification of acute postoperative pain. Participants will: * Take oxycodone + parecoxib sodium or placebo + parecoxib sodium combinations before the surgical incision * Cooperate with the follow-up staffs and complete some checkups or tests within 3 months after the operation.

Conditions

  • Oxycodone
  • Chronic Pain, Postoperative

Interventions

  • oxycodone and parecoxib sodium combinationsDrug

    Participants will receive 0.1ml/kg oxycodone (1mg/ml) and 2 ml parecoxib sodium (20 mg/ml) combinations after the anesthesia induction but before the surgical incision. Oxycodone is administered 5 minutes after parecoxib sodium administration.

  • Placebo and parecoxib sodium combinationsDrug

    Participants will receive 0.1ml/kg placebo (0.9% saline) and 2 ml parecoxib sodium (20 mg/ml) combinations after the anesthesia induction but before the surgical incision. Placebo is administered 5 minutes after parecoxib sodium administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Visceral pain scores in the surgical area at 90 days postoperatively.Time frame: 90 days after the surgery
  2. The incidence of moderate to severe visceral pain at 90 days postoperatively.Time frame: 90 days after the surgery

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.